Table: Towa Pharmaceutical -2018/19 group forecast
Feb 12 (Reuters) -
Towa Pharmaceutical Co Ltd
CONSOLIDATED EARNINGS ESTIMATES
(in billions of yen unless specified)
Full Year to Full Year to
Mar 31, 2019 Mar 31, 2019
LATEST PREVIOUS
FORECAST FORECAST
Sales 104.00 102.80
Operating 15.00 12.00
Recurring 16.30 12.20
Net 11.50 8.95
EPS 701.09 yen 545.63 yen
NOTE - Towa Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4553.T
Recent news on TOWA PHARMACEUTICAL
See all newsTable: Towa Pharmaceutical -Q1 group results
Notice Of Acquisition Of Shares Of Tanabe Pharma Factory And Transfer Of Manufacturing And Marketing Approvals
Brief: Breckenridge Launches Tofacitinib Tablets, Generic Equivalent Of Xeljanz By Pfizer
Table: Towa Pharmaceutical -2025/26 parent results
Table: Towa Pharmaceutical -2025/26 group results